Heterogenous expression of E cadherin and p53 in prostate cancer clinical implications. BIOMED II markers for prostate cancer study group
Number of pages
SourceModern Pathology, 11, 3, (1998), pp. 276-281
Article / Letter to editor
Display more detailsDisplay less details
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.